We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| BioMarin Pharmaceutical Inc | NASDAQ:BMRN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.80 | -2.15% | 82.00 | 80.55 | 105.00 | 84.80 | 82.32 | 84.80 | 1,632,894 | 05:00:10 |
From May 2019 to May 2024
SAN RAFAEL, Calif., Feb. 8, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Leerink Partners 6th Annual Global Healthcare Conference on February 16, 2017 at 1:00pm ET, in New York City. Management will also participate in the Cowen and Company 37th Annual Health Care Conference on March 7, 2017 at 11:20am ET in Boston and the Barclays Global Healthcare Conference on March 15, 2017 at 8:00am ET, in Miami. To access the live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
|
Contacts: |
|
|
Investors |
Media |
|
Traci McCarty |
Debra Charlesworth |
|
BioMarin Pharmaceutical Inc. |
BioMarin Pharmaceutical Inc. |
|
(415) 455-7558 |
(415) 455-7451 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biomarin-to-attend-three-investor-conferences-in-1q17-300402955.html
SOURCE BioMarin Pharmaceutical Inc.
Copyright 2017 PR Newswire
1 Year BioMarin Pharmaceutical Chart |
1 Month BioMarin Pharmaceutical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
